|
| Pfizer Receives Conditional Approval for Tislelizumab in the Treatment of Relapsed or Refractory Extranodal NK/T-cell Lymphoma (ENKTL) |
| Editor:xuezhe Clicks:0Date:2023-11-3 15:37:28 |
| Keyword:Extranodal |
| Healthoo Information: |
|
Pfizer Receives Conditional Approval for Tislelizumab in the Treatment of Relapsed or Refractory Extranodal NK/T-cell Lymphoma (ENKTL)
|
|
|
|
|
